Intellipharmaceutics International Inc. announced that it has appointed Domenic Della Penna as its new Chief Financial Officer, effective November 24, 2014. Mr. Della Penna brings considerable expertise and industry experience to the company. He had previously served as CFO of Teva Canada Limited since December 2010, and he had also simultaneously served as Interim CFO of Teva North America Generics in the United States since December 2013.

His responsibilities and accomplishments in those roles included enhancements to strategic planning processes and financial systems, integration of assets acquired in the purchase of ratiopharm Canada by Teva, business development, and the negotiation of in-licensing opportunities, mergers and acquisitions. Prior to his time at Teva, Mr. Della Penna was the CFO of Timothy's Coffees of the World, and Vice President of Finance of Diageo Canada Inc.